SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-192035
Filing Date
2022-07-12
Accepted
2022-07-12 16:35:38
Documents
13
Period of Report
2022-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d328479d8k.htm   iXBRL 8-K 26693
2 EX-10.1 d328479dex101.htm EX-10.1 101706
  Complete submission text file 0001193125-22-192035.txt   286477

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA freq-20220708.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20220708_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20220708_pre.xml EX-101.PRE 11709
7 EXTRACTED XBRL INSTANCE DOCUMENT d328479d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 221079475
SIC: 2834 Pharmaceutical Preparations